• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Med Case Rep . Clinical outcome of bronchoalveolar lavaged COVID ARDS patients

tetano

Editor, Senior Moderator
Respir Med Case Rep


. 2022 Mar 17;37:101633.
doi: 10.1016/j.rmcr.2022.101633. eCollection 2022.
Clinical outcome of bronchoalveolar lavaged COVID ARDS patients


Zablon Mesfin Anbessie[SUP] 1 [/SUP], Dawit Kebede Huluka[SUP] 2 [/SUP], Zelalem Abdisa Kenea[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: One of the biggest pandemics of the human race, Coronavirus disease, has reported mortality rates as high as 80% for critically ill patients. It has killed more than 3.9 million people worldwide with no strongly proven management options to decrease its mortality. One of the options gaining interest is fiberoptic bronchoscopy and bronchoalveolar lavage. Our study was conducted to assess the clinical outcome of intubated Coronavirus disease patients that had a fiberoptic bronchoscopy and bronchoalveolar lavage done.
Methods and materials: A consecutive prospective case series of intubated patients with critical Coronavirus disease pneumonia were conducted at Bethzatha general hospital from April 20, 2021, to July 30, 2021 GC.
Results: Five patients with a median age of 55 years were included in the study. The median APACHE II, SAPS II, and SOFA scores on admission were 13, 37, and 4 respectively. The difference in the mean values of; positive end-expiratory pressure, static compliance, plateau pressure, fractional inspired oxygen, and arterial oxygen tension to fractional inspired oxygen ratio between the time of intubation and the last fiberoptic bronchoscopy and bronchoalveolar lavage were 4.4 cmH[SUB]2[/SUB]O, 11 ml/cmH[SUB]2[/SUB]O, 6.2 cmH[SUB]2[/SUB]O, 45%, and 76 mmHg. All patients were liberated from mechanical ventilation.
Conclusion: - There was a numerically and clinically significant improvement in lung mechanics and oxygenation leading to a 100% ventilator liberation rate. Fiberoptic bronchoscopy and bronchoalveolar lavage in Coronavirus disease patients can improve lung mechanics, oxygenation, and rates of extubation.

Keywords: Bronchoalveolar lavage; Bronchoscopy; COVID; Extubation; Lung mechanics; Oxygenation.
 
Back
Top Bottom